Hormonal
Oligofructose (OFS) improves glucose tolerance and hepatic insulin sensitivity in high-fat-fed diabetic mice, but these benefits strictly require a functional Glucagon-Like Peptide 1 Receptor (GLP-1R).
If you are looking to use oligofructose to help manage blood sugar, understand that its effectiveness depends on your body's ability to respond to GLP-1. In animal models, if the GLP-1 receptor is blocked or missing, oligofructose provides no metabolic benefit. This suggests that individual variations in GLP-1 receptor function might influence how well this specific fiber works for glucose control.
In summary, our data show that the antidiabetic actions of OFS require a functional GLP-1 receptor.
Why this rating
High-quality mechanistic evidence using both pharmacological blockade (antagonist) and genetic knockout models in a defined animal model of diabetes.
Source
Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor
Patrice D. Cani et al. · Diabetes · 2006
DOI 10.2337/db05-1360
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →